V
Vladimír Tesař
Researcher at First Faculty of Medicine, Charles University in Prague
Publications - 96
Citations - 2322
Vladimír Tesař is an academic researcher from First Faculty of Medicine, Charles University in Prague. The author has contributed to research in topics: Kidney disease & Hemodialysis. The author has an hindex of 25, co-authored 95 publications receiving 1980 citations. Previous affiliations of Vladimír Tesař include Charles University in Prague.
Papers
More filters
Journal ArticleDOI
Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis.
David Jayne,Annette Bruchfeld,Lorraine Harper,Matthias Schaier,Michael Venning,Patrick B. Hamilton,Volker Burst,Franziska Grundmann,Michel Jadoul,Istvan Szombati,Vladimír Tesař,Mårten Segelmark,Antonia Potarca,Thomas J. Schall,Pirow Bekker +14 more
TL;DR: In conclusion, C5a receptor inhibition with avacopan was effective in replacing high-dose glucocorticoids in treating vasculitis.
Journal ArticleDOI
Advanced glycoxidation end products in chronic diseases—clinical chemistry and genetic background
TL;DR: Recent advances in understanding the pathogenesis of chronic diseases provide new possibilities for diagnostics and monitoring of severely ill patients, however, further studies are still required to establish efficient therapeutical strategies.
Journal ArticleDOI
Management of patients with diabetes and CKD: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
Vlado Perkovic,Vlado Perkovic,Rajiv Agarwal,Paola Fioretto,Brenda R. Hemmelgarn,Adeera Levin,Merlin C. Thomas,Merlin C. Thomas,Christoph Wanner,Bertram L. Kasiske,David C. Wheeler,Per-Henrik Groop,Per-Henrik Groop,George L. Bakris,Mark E. Cooper,Dong Wan Chae,Michael H. Davidson,Ian H. de Boer,Dick de Zeeuw,Alessia Fornoni,Luigi Gnudi,Charles A. Herzog,Adriana M. Hung,Tazeen H. Jafar,Meg Jardine,Vivekanand Jha,Linong Ji,Steven E. Kahn,Robyn G Langham,Edgar V. Lerma,Ronald C.W. Ma,Hirofumi Makino,Michel Marre,Michael Mauer,Kaj Metsärinne,Robert G. Nelson,Roberto Pecoits-Filho,Carol A. Pollock,Mohan Rajapurkar,Peter Rossing,Ivan Rychlik,Kumar Sharma,Robert Stanton,Vladimír Tesař,Ilkka Tikkanen,Charles R.V. Tomson,Robert D. Toto,Yusuke Tsukamoto,Katherine R. Tuttle,Takashi Wada,Winfred W. Williams,Hong Zhang,Sophia Zoungas +52 more
TL;DR: The current state of knowledge regarding optimal glycemic control, current antidiabetic agents and their safety, and new therapies being developed to improve kidney function and cardiovascular outcomes for this vulnerable population of people with diabetes are assessed.
Journal ArticleDOI
A nationwide blood spot screening study for Fabry disease in the Czech Republic haemodialysis patient population
Miroslav Merta,Jana Reiterova,Jana Ledvinová,Helena Poupětová,Robert Dobrovolný,Romana Rysava,Dita Maixnerova,Jan Bultas,Jiří Motáň,Jitka Slivkova,Doris Sobotova,Jana Smrzova,Vladimír Tesař +12 more
TL;DR: Blood spot screening (BSS) represents a promising screening tool that has proven to be convenient and effective in uncovering unrecognized FD patients among the chronic HD population in Czech Republic.
Journal ArticleDOI
Matrix Metalloproteinases in Renal Diseases: A Critical Appraisal.
TL;DR: A better understanding of the MMPs’ role in renal remodeling may open the way to new interventions favoring deleterious renal changes in a number of kidney diseases.